$79.99
Research Studies:
In stock
FREE Shipping on
orders over $200
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Sermorelin 10mg is a research-use-only laboratory material supplied for controlled research workflows, compound characterization, and analytical documentation review. It is manufactured under rigorous quality standards to support consistency, traceability, and batch-specific verification for qualified laboratory settings.
Sermorelin 10mg is intended strictly for laboratory research use only. This product is not intended for human or animal consumption, therapeutic use, diagnostic use, clinical use, veterinary use, or as a food, drug, cosmetic, dietary supplement, or household product.
| CAS No. | 86168-78-7 |
|---|---|
| Purity | ≥99% |
| Sequence | H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 |
| Molecular Formula | C149H246N44O42S |
| Molecular Weight | 3357.88 g/mol |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Applications | Growth hormone release studies, aging research, body composition improvement |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy Sermorelin online should evaluate Sermorelin as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate Sermorelin research material for controlled research procurement through Pure Lab Peptides.
Researchers can buy Sermorelin online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase “buy Sermorelin online” is addressed here as laboratory research procurement intent, not personal-use intent. In this context, the searcher is typically a qualified researcher, laboratory buyer, research institution, or technical procurement team comparing research-use-only sourcing options and supplier documentation.
Research procurement focuses on whether the supplier presents Sermorelin research-use-only labeling clearly, makes batch-specific COA documentation available, provides purity and identity information, supports lot-level traceability, and avoids language that implies human-use, animal-use, therapeutic, diagnostic, or consumer positioning. FDA RUO guidance for in vitro diagnostic products emphasizes that research-use labeling should align with intended use, and 21 CFR Part 809 provides an example of prominent RUO labeling language in that specific IVD context; those sources are cited here as labeling context, not as a statement that Sermorelin is an IVD product [1] [2].
For Sermorelin procurement, the practical question is not how a compound is used. The question is whether the material can be documented as a laboratory research compound through RUO labeling, a Sermorelin COA, identity testing information, purity documentation, product-form details, storage information, and supplier transparency.
Sermorelin is categorized here as a GHRH-pathway, secretagogue-category research peptide. Public compound databases identify Sermorelin with the molecular formula C149H246N44O42S, and FDA substance records list names associated with growth hormone-releasing factor (human) 1-29 peptide amide [3] [4]. ChEMBL maintains a record for Sermorelin acetate, which can help researchers distinguish database identity records from supplier-specific batch documentation [5].
In neutral laboratory terminology, Sermorelin is a peptide research material. The National Cancer Institute defines a peptide as a molecule containing two or more amino acids, a basic classification that supports the use of peptide-specific identity and purity review methods when evaluating laboratory materials [6]. Researchers should distinguish this general peptide classification from any product-use claim.
Published scientific context for Sermorelin is commonly connected to growth hormone-releasing hormone receptor literature. UniProt identifies the human GHRH receptor as Q02643, and peer-reviewed reviews describe the receptor and pathway context at a molecular and signaling level [7] [8] [9] [10]. This background is useful for literature classification, not product-use guidance.
Database records should also be interpreted carefully. ChEMBL is a curated bioactivity database, but a database listing is not a substitute for batch-specific supplier documentation [11]. FDA Substance Registration System pages also note that UNII availability does not imply regulatory review or approval [12]. Pathway relevance in published literature does not establish product-use guidance for RUO materials.
Researchers search buy Sermorelin online to compare research-use-only product availability, supplier documentation, labeling consistency, and analytical transparency. A laboratory buyer may need to verify whether the supplier provides a batch-specific COA, whether the product name matches the documentation, whether the lot number is traceable, and whether the material form is appropriate for a controlled laboratory workflow.
Searches for buy Sermorelin should not be treated as consumer shopping intent. In RUO procurement, the relevant comparison points are Sermorelin purity documentation, Sermorelin identity testing, Sermorelin supplier documentation, storage information, product-form disclosure, and whether the supplier avoids dosing, therapeutic, personal-use, animal-use, or clinical-use language.
For Pure Lab Peptides, Sermorelin 10mg is positioned as a research-use-only material with a batch-specific COA available, a stated purity claim of >=99%, and lyophilized powder form. Researchers should review the product page and batch-specific documentation before procurement.
Researchers evaluating where to buy Sermorelin online for laboratory research should prioritize quality signals that can be reviewed before procurement and documented after receipt. The strongest signals are not marketing claims. They are verifiable records: RUO labeling, batch-specific COA access, lot number consistency, method references, identity support, storage guidance, and transparent supplier language.
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review the batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
A Sermorelin COA should be reviewed as a batch-specific record, not as generic product copy. Laboratory buyers should look for compound name, lot number, test date, purity percentage, testing method, identity confirmation, molecular weight or mass data where included, product-form consistency, and storage documentation. FDA analytical guidance describes analytical procedures as part of documentation for identity, strength, quality, purity, and potency in regulated drug and biologic contexts; RUO buyers can use the same general logic of method-aware documentation review without treating the RUO material as a clinical product [13].
Analytical method review matters because different methods answer different questions. ICH Q2(R2) discusses validation principles for analytical procedures, while ICH Q14 discusses science-based analytical procedure development [14] [15]. USP General Chapter <621> provides chromatography terminology and system-suitability context relevant to HPLC review [16]. ISO/IEC 17025 describes competence requirements for testing and calibration laboratories, which can help procurement teams understand why laboratory accreditation, method suitability, and reporting discipline matter [17].
For peptide research materials, peer-reviewed analytical literature supports the use of chromatography, mass spectrometry, LC-MS, and reference-standard approaches for identity, impurity, and purity evaluation. Publications on synthetic peptide reference standards, LC-MS characterization workflows, and mass spectrometry methods illustrate why identity confirmation and purity review should be considered together [18] [19] [20].
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. Studies of peptide impurities show that structurally related peptide materials may require mass-aware and chromatographic evaluation, which is why a Sermorelin COA should be read as a documentation package rather than a single number [21] [22]. Storage and handling records should also be reviewed because stability guidance emphasizes defined conditions and stability-indicating procedures in the broader quality context [23].
Published literature has examined Sermorelin and GHRH-related compounds in scientific settings outside the scope of RUO product use. A review by Prakash and Goa describes Sermorelin as a 29-amino-acid analogue of human GHRH and discusses historical clinical literature, but that literature should not be converted into claims for research-use-only materials [24]. Published clinical literature should not be interpreted as use guidance for RUO materials.
For procurement purposes, the most relevant literature categories are compound identity, peptide classification, receptor-pathway context, and analytical verification. Reviews of GHRH and the GHRH receptor describe molecular and receptor biology that can help researchers classify literature context, while recent reviews discuss GHRH receptor and splice-variant research more broadly [8] [9] [10] [25].
The limitations are important. Literature may be database-based, analytical, in vitro, preclinical, review-based, or clinical. Each category has a different evidentiary role. A receptor review can support neutral pathway classification; it does not support product-use instructions. A compound database can support identity lookup; it does not replace a batch-specific COA. A clinical paper can document historical research; it does not provide guidance for RUO procurement, handling, or use.
Pathway relevance in published literature does not establish product-use guidance for RUO materials. For Sermorelin research-use-only procurement, literature context should be used to understand nomenclature, category, identity, and documentation expectations, not to infer outcomes.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, synonyms, or classification | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | GHRH receptor, GHRH pathway, peptide classification, or model-specific research area | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, impurity review, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form, documented storage information, and handling considerations | Laboratory documentation | Supports research workflow planning |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “Sermorelin is discussed in published research related to GHRH pathway and peptide receptor literature.” | Describes literature context without making a product claim | “Sermorelin helps with a human outcome.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy Sermorelin for results.” |
| “Pure Lab Peptides supplies Sermorelin as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies Sermorelin for therapy.” |
| “The phrase buy Sermorelin online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy Sermorelin online for personal use.” |
| “Sermorelin identity testing should be reviewed with purity documentation and lot traceability.” | Connects procurement to analytical records | “A purity number proves everything needed.” |
Pure Lab Peptides presents Sermorelin 10mg as a research-use-only material. The product is supplied as lyophilized powder, includes a stated >=99% purity claim, and has a batch-specific COA available for review. Researchers should review the Pure Lab Peptides Sermorelin research-use-only product details for RUO labeling, product details, purity information, and batch-specific documentation.
Supplier transparency is especially important for Sermorelin supplier documentation because procurement teams need a consistent chain of records. The product page, COA, lot number, storage and handling documentation, and product-form description should align. If a laboratory is comparing multiple RUO peptide materials, the broader research peptide collection, documentation-focused research articles, and shipping and returns information may help with procurement planning.
Buy Sermorelin online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, product form, storage information, and supplier transparency.
Published literature can help researchers understand compound identity, nomenclature, category, and pathway context. It should not be treated as product-use guidance for Sermorelin research-use-only material. RUO procurement is based on labeling, COA review, identity testing, purity documentation, and lot traceability.
Sermorelin purity documentation is important, but a purity percentage alone does not confirm complete identity. Researchers should evaluate the COA, analytical method, identity information, lot number, product name, product form, and storage documentation together before adding the material to laboratory records.
A generic specification sheet is not the same as a batch-specific Sermorelin COA. Research procurement teams should confirm that the COA corresponds to the lot being reviewed. Lot-specific documentation supports traceability, internal recordkeeping, and a clearer connection between the received material and analytical records.
RUO labeling does not support human use, animal use, clinical use, diagnostic use, veterinary use, or consumer positioning. For Sermorelin research-use-only procurement, the relevant documentation is supplier labeling, batch-specific COA access, analytical testing information, product-form details, and storage guidance.
Supplier claims should not replace analytical documentation. Researchers should prioritize the Sermorelin COA, identity testing, purity documentation, lot number, product-form description, and storage records. RUO-safe supplier language should support documentation review rather than imply outcomes, protocols, or product-use claims.
Researchers can buy Sermorelin online for laboratory research from an RUO supplier that provides clear labeling, batch-specific COA documentation, purity information, identity support, storage guidance, and lot-level traceability. Pure Lab Peptides provides a Sermorelin 10mg product page for qualified research procurement review.
Before buying Sermorelin online, researchers should check RUO labeling, the batch-specific Sermorelin COA, purity documentation, identity testing information, lot number consistency, product-form details, storage documentation, and supplier language. The supplier should avoid human-use, animal-use, dosing, therapeutic, or personal-use positioning.
A COA matters when buying Sermorelin because it connects procurement to batch-specific analytical documentation. Researchers should review the compound name, lot number, test date, purity data, analytical method, and identity information. The COA should be evaluated with labeling, product-form details, and storage records.
Sermorelin discussed on this page is not intended for human or animal consumption. It is addressed only as a research-use-only laboratory material. Procurement teams should evaluate labeling, COA documentation, identity testing, purity data, supplier transparency, and storage information within controlled laboratory procurement processes.
Research use only means Sermorelin is positioned as a laboratory research material, not as a consumer product, clinical product, diagnostic product, veterinary product, or therapeutic product. For procurement teams, RUO evaluation centers on documentation, lot traceability, purity records, identity support, and supplier language.
Published literature about Sermorelin should be interpreted as scientific context for compound identity, peptide classification, GHRH pathway research, or analytical review. It should not be converted into product-use guidance for RUO materials. Researchers should separate literature review from procurement documentation and supplier evaluation.
Qualified researchers evaluating Sermorelin should review product labeling, COA status, identity documentation, purity information, storage guidance, and supplier transparency. Review the Sermorelin product page for RUO labeling, purity information, and available batch-specific documentation before selecting any research-use-only material.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.